OptiNose Stock Forum

$Processa Pharmaceuticals(PCSA.US)$ $Barfresh Food(BRFH.US)$ $Intelligent Living Application(ILAG.US)$ $SuperCom(SPCB.US)$ $reAlpha Tech(AIRE.US)$ $OptiNose(OPTN.US)$
📊⚡️📊

$OptiNose(OPTN.US)$ SOPTN XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal
Polyps

$OptiNose(OPTN.US)$ Approved 🚀🚀🚀🚀

Last week’s PDUFAs:
$BeiGene(BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb(BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ®  + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals(VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ® 
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia(EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...

$OptiNose(OPTN.US)$ OptiNose (NASDAQ:OPTN) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 47.06 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $19.86 million which beat the analyst consensus estimate of $19.23 million by 3.30 percent. This is a 4.75 percent decrease over sales of $20.86 million the same period last year.

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia(EYEN.US)$ $Vanda Pharmaceuticals(VNDA.US)$ $Mirum Pharmaceuticals(MIRM.US)$ $Madrigal Pharmaceuticals(MDGL.US)$ $Geron(GERN.US)$ $Bristol-Myers Squibb(BMY.US)$ $2seventy bio(TSVT.US)$ $Legend Biotech(LEGN.US)$ $OptiNose(OPTN.US)$ $Orchard Therapeutics(ORTX.US)$ $Merck & Co(MRK.US)$ $Akebia Therapeutics(AKBA.US)$ $AstraZeneca(AZN.US)$ $Liquidia(LQDA.US)$ $Esperion Therapeutics(ESPR.US)$ $Regeneron Pharmaceuticals(REGN.US)$ $BeiGene(BGNE.US)$

A huge 3 day span will see 7 companies in front of the review board:
$Mirum Pharmaceuticals(MIRM.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
$Geron(GERN.US)$
$Bristol-Myers Squibb(BMY.US)$
$Legend Biotech(LEGN.US)$
$2seventy bio(TSVT.US)$
$OptiNose(OPTN.US)$